Pmlive PMLiVE.com is the online home to PME, Communiqué and The Directory. Sign-up for online copies: http://www.pmlive.com/register
(1)

Sign-up for online copies: http://www.pmlive.com/register

You can also find us here:
Twitter: https://twitter.com/pmlivecom
LinkedIn: https://www.linkedin.com/company/pmgroup-worldwide-ltd
Google Plus: https://plus.google.com/+pmlivecom
YouTube: https://www.youtube.com/user/PMLiVETV

The PMLiVE website and its associated monthly print magazine Pharmaceutical Market Europe (PME) and twice-yearly p

rint titles Communiqué and The Directory are published by PMGroup. The website offers the latest pharma news, analysis, jobs and events, including the annual Pharmaceutical Market Excellence Awards (PMEAs), Communiqué Awards and the Quality in Care (QiC) Programme.

Merck agrees deal with Cidara Therapeutics worth almost $9.2bn
21/11/2025

Merck agrees deal with Cidara Therapeutics worth almost $9.2bn

Cidara’s long-acting viral flu drug showed significant protection in phase 2 results

The Future of MSL Training – How Digital Technologies Are Shaping Success
21/11/2025

The Future of MSL Training – How Digital Technologies Are Shaping Success

Discover how pharmaceutical companies are using asynchronous platforms and microlearning to eliminate geographical barriers, track performance, and achieve cost-effective, consistent training for global teams.

PMEA 2025: a celebration of excellence in pharmaceutical marketing
21/11/2025

PMEA 2025: a celebration of excellence in pharmaceutical marketing

This year’s Awards, held at the Sheraton Grand in London, included 20 categories

J&J receives positive NICE recommendation for multiple myeloma treatment
20/11/2025

J&J receives positive NICE recommendation for multiple myeloma treatment

The treatment is approved for use within the NHS in England and Wales

Younger, not invisible: rewriting cancer care – starting with the pancreas
20/11/2025

Younger, not invisible: rewriting cancer care – starting with the pancreas

By Sommer Bazuro

Voices of Change: Women Leading the Menopause Movement
20/11/2025

Voices of Change: Women Leading the Menopause Movement

For decades, menopause has been swept under the rug, or into the dark corners of clinicians’ offices, often dismissed as something women just had to “get past” and hardly worth discussing. In this episode of “Hear From Her,” learn how three leaders in menopause medicine are building a new ...

The Power of the Pivot: How Nurse Practitioners are Closing Care Gaps for Women
20/11/2025

The Power of the Pivot: How Nurse Practitioners are Closing Care Gaps for Women

The career path of a Nurse Practitioner is often envisioned as a straight line: clinical practice, specialization, perhaps a supervisory role. But for two pioneering NPs, Laura Demuth and Jackie Gianelli, that line took them into the executive suite and a new era of care. Their journeys, shared in a...

Women Leaders Rewriting the Protocols of Rare Disease Care
20/11/2025

Women Leaders Rewriting the Protocols of Rare Disease Care

The true measure of a medical leader is the courage to act when existing systems fail the patient. This is the professional and personal ethos of clinical immunologist Dr. Hilary Longhurst and clinical scientist Mrinal Shah. These women are not only advancing the science of gene editing for rare dis...

Gilead reports Trodelvy breast cancer trial missed primary survival endpoint
20/11/2025

Gilead reports Trodelvy breast cancer trial missed primary survival endpoint

The drug treatment is being evaluated in several ongoing phase 3 trials

Biogen and Eisai receive MHRA approval for updated dosing of early Alzheimer’s treatment
19/11/2025

Biogen and Eisai receive MHRA approval for updated dosing of early Alzheimer’s treatment

The MHRA approval for IV dosing comes following positive results from the global phase 3 trial

Medscape Wins Anthem Award for Rare Disease Education Platform
19/11/2025

Medscape Wins Anthem Award for Rare Disease Education Platform

Newark, NJ - - Medscape, the leading digital platform for physicians and healthcare professionals (HCPs), has been awarded a 2025 Silver Anthem Award for

InflaRx reports positive phase 2 results for HS and CSU treatments
19/11/2025

InflaRx reports positive phase 2 results for HS and CSU treatments

Topline results demonstrated treatment efficacy for both conditions

Address

Little Bookham
KT233JG

Opening Hours

Monday 9:30am - 5:30pm
Tuesday 9:30am - 5:30pm
Wednesday 9:30am - 5:30pm
Thursday 9:30am - 5:30pm
Friday 9:30am - 5:30pm

Alerts

Be the first to know and let us send you an email when Pmlive posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Share

Category